Exagen
Exagen Q3 Revenues Decline 7 Percent
The firm said its Q3 revenues were negatively impacted by $1.2 million in one-time adjustments.
In Brief This Week: Thermo Fisher Scientific, Labcorp, Personalis, Exagen, Co-Diagnostics, More
News items for the week of Aug. 5, 2024.
Earnings Roundup: Renalytix, DermTech, Oncocyte, Aspira Women's Health, Exagen, More
Renalytix, DermTech, Oncocyte, Aspira Women's Health, and others reported their first quarter earnings this week.
In Brief This Week: Quest Diagnostics, Guardant Health, Exagen, Centogene, Enable Biosciences, More
News items for the week of March 18, 2024.
In Brief This Week: BioMérieux, Labcorp, Opko Health, Exagen, MyHealthChecked, Sequentify
News items for the week of Jan. 8, 2024.
May 11, 2022
Exagen Q1 Revenues Drop 2 Percent
Nov 10, 2021
Exagen Q3 Revenues Rise 14 Percent
Oct 25, 2021
Exagen Enters $27.2M Debt Refinancing Agreement
Aug 9, 2021
Exagen Posts 43 Percent Increase in Q2 Revenues
May 11, 2021
Exagen Q1 Revenues Grow 10 Percent
Mar 23, 2021